Literature DB >> 7680492

The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis.

T Miyata1, J Takeda, Y Iida, N Yamada, N Inoue, M Takahashi, K Maeda, T Kitani, T Kinoshita.   

Abstract

The glycosylphosphatidylinositol (GPI) anchor is a membrane attachment structure of many proteins and occurs in a wide variety of eukaryotes from yeasts to mammals. The structure of the core of the GPI anchor is conserved in protozoa and mammals and so is its biosynthetic pathway. A complementary DNA encoding a human protein termed PIG-A (phosphatidylinositol glycan-class A) was cloned. PIG-A was necessary for synthesis of N-acetylglucosaminyl-phosphatidylinositol, the very early intermediate in GPI-anchor biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680492     DOI: 10.1126/science.7680492

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  128 in total

1.  X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation.

Authors:  P Keller; G Tremml; V Rosti; M Bessler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  Farming for spare body parts: silk purse or sow's ear.

Authors:  J P Atkinson
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

3.  Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Authors:  Atsushi Narita; Hideki Muramatsu; Yuko Sekiya; Yusuke Okuno; Hirotoshi Sakaguchi; Nobuhiro Nishio; Nao Yoshida; Xinan Wang; Yinyan Xu; Nozomu Kawashima; Sayoko Doisaki; Asahito Hama; Yoshiyuki Takahashi; Kazuko Kudo; Hiroshi Moritake; Masao Kobayashi; Ryoji Kobayashi; Etsuro Ito; Hiromasa Yabe; Shouichi Ohga; Akira Ohara; Seiji Kojima
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

4.  Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Norimitsu Inoue; Tomohisa Izui-Sarumaru; Yoshiko Murakami; Yuichi Endo; Jun-Ichi Nishimura; Ken Kurokawa; Maki Kuwayama; Hiroaki Shime; Takashi Machii; Yuzuru Kanakura; Gabrielle Meyers; Carl Wittwer; Zhong Chen; William Babcock; Debra Frei-Lahr; Charles J Parker; Taroh Kinoshita
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

Review 5.  Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; Antonio M Risitano; John D Lambris
Journal:  Semin Hematol       Date:  2018-02-14       Impact factor: 3.851

6.  Human and mouse Gpi1p homologues restore glycosylphosphatidylinositol membrane anchor biosynthesis in yeast mutants.

Authors:  A Tiede; J Schubert; C Nischan; I Jensen; B Westfall; C H Taron; P Orlean; R E Schmidt
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

7.  Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Authors:  Stella Santarone; Andrea Bacigalupo; Antonio M Risitano; Elena Tagliaferri; Erminia Di Bartolomeo; Anna Paola Iori; Alessandro Rambaldi; Emanuele Angelucci; Alessandra Spagnoli; Federico Papineschi; Stefania Tamiazzo; Marta Di Nicola; Paolo Di Bartolomeo
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

8.  Using the P[wHy] hybrid transposable element to disrupt genes in region 54D-55B in Drosophila melanogaster.

Authors:  Stephanie E Mohr; William M Gelbart
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

9.  Kinetics of CHO A L mutant expression after treatment with gamma radiation, EMS, and asbestos.

Authors:  Stephen B Keysar; Michael H Fox
Journal:  Cytometry A       Date:  2009-05       Impact factor: 4.355

10.  Spontaneously arising red cells with a McLeod-like phenotype in normal donors.

Authors:  David J Araten; Katie J Sanders; Jeffrey Pu; Soohee Lee
Journal:  Mutat Res       Date:  2009-04-02       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.